Tech Center 1600 • Art Units: 1631 1632 1634 1638
This examiner grants 23% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18245128 | COMPOSITIONS AND METHODS OF USE FOR INFUSIBLE EXTRACELLULAR MATRIX | Final Rejection | The Regents of the University of California |
| 18051653 | TCF7L2 MEDIATED REMYELINATION IN THE BRAIN | Final Rejection | University of Rochester |
| 16105625 | METHOD OF PRODUCING THREE-DIMENSIONAL CELL TISSUE | Final Rejection | TOPPAN Holdings Inc. |
| 19361681 | METHODS AND COMPOSITIONS FOR PRODUCING GRANULOSA-LIKE CELLS | Final Rejection | President and Fellows of Harvard College |
| 16314471 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR ORGAN FIBROSIS | Non-Final OA | TOHOKU UNIVERSITY |
| 17224831 | METHODS OF TREATING INFLAMMATION | Non-Final OA | University of South Florida |
| 16794723 | Transcription Factor Mediated Programming Towards Megakaryocytes | Non-Final OA | Cambridge Enterprise Limited |
| 17416311 | ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16971995 | METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16968504 | PROMOTING AND PROTECTING FUNCTIONAL BETA CELL MASS BY SYNTAXIN 4 ENRICHMENT | Non-Final OA | CITY OF HOPE |
| 17906150 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE II | Final Rejection | Mesoblast International Sárl |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy